Skip to content

003000.KS

Bukwang Pharmaceutical Co., Ltd.

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 3,700.00
−1.33%
Ask drillr

Leverage

Debt / equity
—
Net debt / equity
—
Debt / assets
—
Debt / EBITDA
—
Net debt / EBITDA
—

Liquidity & coverage

Current ratio
—
Quick ratio
—
Cash ratio
—
Interest coverage
7.38x
EBITDA / interest
9.51x
Working capital
—

Cash & dividend

FCF / debt
—
Cash flow / debt
—
Dividend per share
KRW 125
Dividend yield
3.4%
Dividend growth 1y
+25.0%

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026